RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
Depository Receipt · US75973T1016 · RNLX · A2P9A5 (XNAS)
Overview
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % -55,71 % -98,47 %

Company Profile for RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES Depository Receipt

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.

Company Data

Name RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
Company Renalytix Plc
Symbol RNLX
Website https://renalytix.com
Primary Exchange XNAS NASDAQ
WKN A2P9A5
ISIN US75973T1016
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Mr. James R. McCullough M.B.A.
Market Capitalization 23 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 1460 Broadway, 10036 New York
IPO Date 2020-07-17

Ticker Symbols

Name Symbol
Frankfurt 2O9A.F
NASDAQ RNLX

More Shares

Investors who RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES hold also have the following shares in their portfolio:
STORAGEVAULT CANADA INC
STORAGEVAULT CANADA INC Share
VONOVIA FIN 19/39 MTN
VONOVIA FIN 19/39 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025